Sensi M L, Parenza M, Parmiani G
J Natl Cancer Inst. 1983 Feb;70(2):291-7.
The possibility of obtaining a syngeneic antitumor effect by immunization with normal allogeneic cells was investigated by tests of the lytic activity of peritoneal exudate cells (PEC) of BALB/c mice immunized with lymphoid cells of either a single strain or a pool of six different allogeneic strains on the syngeneic Moloney virus-induced lymphoma YC8 target and on one of its clones designated YC8-D1. Significant cytotoxicity on both targets but not on two other BALB/c lymphomas was obtained with PEC of BALB/c mice singly immunized to the non-H-2-incompatible but H-2-compatible DBA/2 or B10.D2 lymphoid cells. The lack of lysis of YC8 cells by PEC of BALB/c mice immune to B10.A (H-2k,d) suggests that the in vitro killing was restricted by Kd-IEd region products of the major histocompatibility complex. Pool immunization was effective in generating antitumor cytotoxic lymphocytes only when DBA/2 lymphoid cells were included in the pool. The pattern of reactivity of effectors elicited in (BALB/c x DBA/2)F1 and in (BALB/c x B10.D2)F1 mice by immunization with DBA/2 and B10.D2 cells showed that at least two sets of antigens are recognized on YC8 targets, one shared by DBA/2 and B10.D2 tissues and the other expressed by DBA/2 cells only. Cold target blocking experiments indicated that the same effectors recognized non-H-2 antigens of DBA/2 and the cross-reacting YC8 determinants. The antitumor effect was mediated by T-cells, since it was abrogated by treatment of effectors with anti-Thy 1.2 serum plus complement. These data indicate that determinants defined by cytotoxic T-lymphocytes are expressed on the BALB/c lymphoma YC8 and cross-react with non-H-2 antigens of DBA/2 and B10.D2 strains.
通过用正常同种异体细胞免疫来获得同基因抗肿瘤效应的可能性,已通过对BALB/c小鼠腹腔渗出细胞(PEC)的裂解活性进行检测来研究。这些BALB/c小鼠用单一品系或六个不同同种异体品系的混合淋巴细胞进行免疫,然后检测其对同基因莫洛尼病毒诱导的淋巴瘤YC8靶细胞及其一个名为YC8-D1的克隆的裂解活性。用BALB/c小鼠单独免疫非H-2不相容但H-2相容的DBA/2或B10.D2淋巴细胞后获得的PEC,对这两个靶细胞均有显著的细胞毒性,但对另外两种BALB/c淋巴瘤则无此作用。对B10.A(H-2k,d)免疫的BALB/c小鼠的PEC不能裂解YC8细胞,这表明体外杀伤作用受主要组织相容性复合体的Kd-IEd区域产物限制。只有当混合淋巴细胞中包含DBA/2淋巴细胞时,混合免疫才有效地产生抗肿瘤细胞毒性淋巴细胞。用DBA/2和B10.D2细胞免疫(BALB/c×DBA/2)F1和(BALB/c×B10.D2)F1小鼠所引发的效应细胞的反应模式表明,在YC8靶细胞上至少识别出两组抗原,一组由DBA/2和B10.D2组织共享,另一组仅由DBA/2细胞表达。冷靶阻断实验表明,相同的效应细胞识别DBA/2的非H-2抗原和交叉反应的YC8决定簇。抗肿瘤效应由T细胞介导,因为用抗Thy 1.2血清加补体处理效应细胞可消除该效应。这些数据表明,细胞毒性T淋巴细胞所定义的决定簇在BALB/c淋巴瘤YC8上表达,并与DBA/2和B10.D2品系的非H-2抗原发生交叉反应。